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Introduction
Intracellular pathogens are a major cause of global morbidity
and mortality. While this alone establishes their medical
importance, they are also a focus of special interest because of
their unique lifestyles. Many of these organisms have evolved to
reside within the hostile environment of macrophages. Given that
these innate immune effector cells are normally programmed to
destroy ingested prey and promote the development of adaptive
immunity, this is one of the ultimate paradoxes in the study of
host–pathogen interactions. The success of these microbes is
dependent on diverse strategies including the disruption of
macrophage cell regulation, the ability to nullify macrophage
microbicidal effector mechanisms, and other special adaptations to
an intracellular lifestyle. Here, we review a series of well
established survival paradigms that have emerged that illustrate
this behaviour.
Targeting Critical Signaling Pathways Prevents
Effective Macrophage Activation and Promotes
Survival of Intracellular Pathogens
Activated macrophages form a heterogeneous collection of cells
with functions as diverse as secretion of pro- or anti-inflammatory
mediators, intracellular pathogen killing, induction of T-helper 1
or T-helper 2 cell responses, extracellular matrix synthesis and
tissue repair, and others. Not surprisingly, many intracellular
microbes interfere with host cell signaling in order to prevent or
modulate cellular activation in their favour.
One notable example involves interference with host protein
kinase and phosphatase activities, thereby preventing macrophage
activation. Leishmania release effectors that activate macrophage
phosphotyrosine phosphatases, leading to inhibition of Jak-STAT
and mitogen-activated protein (MAP) kinase signaling [1] (and see
also supplemental references [S1,S2,S3] in Text S1). The Leishmania
surface lipophosphoglycan (LPG) [2] and Mycobacterium tuberculosis
(Mtb) protein kinase G [3] both suppress protein kinase C activity,
thereby inhibiting the macrophage oxidative burst in response to
Leishmania [S4] and attenuating phagocytosis of Mtb [3]. Activation
of PI3K has been observed during infection with Mtb [S5],
Francisella tularensis [4], and Leishmania [5,S6], leading to inhibition of
both apoptosis and pro-inflammatory cytokine secretion with
reciprocal enhancement of anti-inflammatory cytokine production.
Furthermore, pathogens such as Leishmania amazonensis and Mtb
modulate host protein synthesis through effects on protein kinase R,
or interference with Toll-like receptor (TLR)-mediated activation of
the transcription factor NFkB [S7,S8].
Intracellular microbes can shape macrophage phenotypes by
modulating cytokine secretion, which determines the fate of the
downstream host response. Most pathogens inhibit production of
pro-inflammatory cytokines such as IL-12, TNF-a, and IFN-c,
and induce production of anti-inflammatory cytokines such as IL-
10, TGF-b, and IL-4, thereby down-regulating immunopathology
and host defence mechanisms. Importantly, signaling pathways
centered on IFN-c, the predominant inducer of macrophage-
mediated microbicidal functions, are commonly targeted by
intracellular pathogens. Down-regulation of IFN-c receptor
expression or interference with the IFN-c receptor downstream
effectors Jak and STAT have been observed during infection with
Mtb [S9,S10], Trypanosoma cruzi [S11], and Leishmania [S2,S12].
Prolonged survival in macrophages also requires prevention of
adaptive immunity. To this end, Mtb inhibits expression of the
class II transactivator and MHC class II molecules and antigen
presentation, thereby evading effective recognition by CD4
+ T
cells (for a review see [6]). Similar phenomena have been observed
during infection with Toxoplasma gondii [S13], Leishmania [S14,S15],
and Salmonella [S16].
Coping with an Intracellular Lifestyle May Involve
Escaping from the Phagosome, Modulating
Phagosome Maturation, or Liaisons with
Autophagosomes
Phagocytic uptake of pathogens by macrophages results in the
formation of vacuoles that, by interactions with vesicles of the
endosomal system, are intended to transform into microbicidal
phagolysosomes through a process known as phagosome matura-
tion. Intracellular pathogens residing within phagosomes, howev-
er, have evolved mechanisms to either subvert or delay the
maturation process, or to escape from their vacuoles altogether.
Organisms such as Mtb and Salmonella block maturation by
targeting key regulatory pathways including PI 3-kinase signalling
and small GTPase Rab conversions, which ordinarily promote the
acquisition and activation of effectors needed for maturation to
occur. Both Mtb [7,S17,S18] and Salmonella enterica typhimurium
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phorylate phosphoinositides on the phagosome membrane. Mtb
[S21–S25] and S. typhimurium [S26,S27] also actively prevent the
acquisition and activation of Rab7 and its downstream effectors.
Similarly, S. typhimurium interferes with Rab9 recruitment to the
Salmonella-containing vacuole [S28]. In addition, Mtb secretes
protein tyrosine phosphatase A, which interferes with late
endosome/lysosome vesicular interactions [8], and its cell wall
lipid ManLAM modulates MAP kinase signaling, leading to
phagosome maturation arrest between early and late stages
[S29,S30].
Other pathogens such as Legionella pneumophila [S31,S32],
Leishmania [S33–S35], and Coxiella burnetti [S36–S38] do not arrest,
but rather delay, phagosome maturation in order to provide time
to switch from an extracellular form to one that is able to cope
with conditions in a phagolysosome [9]. Leishmania delay
maturation using their surface-associated lipophosphoglycan,
during which time these protozoan parasites switch from the
promastigote form to the phagolysosome-resistant amastigote form
[S39]. Legionella [S40] and Coxiella secrete effectors via their Type
IV secretion system that aid in delaying phagosome maturation. In
addition, Legionella surface composition and the secretion of
microvesicles delay maturation independent of Type IV secretion
[S41].
Interestingly, intracellular pathogens not only adapt to resist the
harsh conditions in the phagolysosome, but may actually require
lysosomal as well as autophagosomal interactions to facilitate the
delivery of nutrients [10,S42–S45]. Autophagy is a mechanism
whereby cells recycle cellular components by enclosing them in
autophagosomes that fuse with lysosomes to mediate degradation
of their contents. Although autophagy plays a role in host defence
by encapsulating and degrading microbes, this pathway is also
important in facilitating survival of Chlamydia [S46], Brucella abortus
[S47], and Yersinia [S48,S49].
Not all pathogens that enter the host cell in a phagosome
remain there. Listeria monocytogenes [S50,S51] and Shigella flexneri
[S52,S53] escape from phagosomes by forming actin tails. This
enables them to move within the infected cell, preventing their
recognition and killing by autophagy and allowing dissemination
to neighbouring cells [11]. Unlike L. monocytogenes and S. flexneri,
which leave their phagosomes at an early stage of phagosome
maturation, the protozoan T. cruzi escapes from its vacuole after
lysosomal fusion, when low pH conditions favour hemolysin
activity [S54,S55].
Acquisition of Essential Nutrients and Co-Factors
from Host Cells Promotes Growth and Replication
of Intracellular Pathogens
In order to survive and replicate within their host cells, microbes
must gain access to nutrients. Pathogens such as L. monocytogenes
and S. flexnerii escape from phagosomes into the cytosol, which is
relatively nutrient-rich. In contrast, persistent phagosome dwellers
face restrictive conditions for access to metal cations such as Fe
2+,
Mn
2+, and Co
2+, as these are transported out of the phagosome via
the Nramp (natural resistance–associated macrophage protein)
transporter [12,S56]. To compete against Nramp, certain bacteria
express an Nramp homolog [S57,S58]. This allows them to
acquire cation cofactors that are essential for bacterial reactive
oxygen intermediate (ROI) detoxifying enzymes [13]. Since
greater than 80% of total body iron is bound to heme, and iron
is further sequestered by transferrin and lactoferrin, free iron is in
short supply in host cells. This serves as an important mechanism
of resistance against microbial invaders. To obtain iron, Leishmania
express receptors that allow internalisation of hemoglobin,
transferrin, and lactoferrin [14,S59,S60], and exploit the iron
labile pool in macrophages [S61]. Bacterial pathogens express
iron-chelating siderophores such as mycobacterial mycobactins
[15], salmochelin released by Salmonella and Shigella [S62,S63], and
Yersinia yersiniabactin [S64], all of which compete with transferrin
or lactoferrin for iron. In conjunction with siderophore produc-
tion, Mtb also express a heme uptake system [S65].
In addition to iron, pathogens whose niche is restricted to
phagosomes must also acquire carbon. Mtb uses fatty acids and
cholesterol as a carbon source and this is essential for persistence
[16,S66,S67]. Salmonella uses host glucose, phosphorylated carbo-
hydrates, and fatty acids as carbon sources [S68,S69]. Pathogens
such as Leishmania [S42], Chlamydia [S46], and Coxiella
[S44,S70,S43] also reside in phagolysosomes that intersect with
autophagosomes that provide amino acids and other nutrients.
Strategies Used to Prevent or Resist the
Phagocyte Oxidative Burst or the Formation of
Reactive Nitrogen Intermediates
A major weapon in the macrophage antimicrobial arsenal is the
phagocyte oxidative burst, which results in the generation of ROIs
such as superoxide, hydrogen peroxide, and hypochlorous acid.
The importance of the oxidative burst to host defence is illustrated
by patients with chronic granulomatous disease who, due to
oxidase mutations, cannot form ROIs and consequently suffer
from recurrent bacterial and fungal diseases.
There are at least two strategies by which intracellular
pathogens modulate the oxidative burst: (1) by preventing
assembly of the macrophage NADPH oxidase that produces
ROIs, or (2) by detoxifying ROIs as they are formed. The
Salmonella pathogenicity island (SPI)-2, which encodes for a Type
III secretion apparatus, is necessary for preventing NADPH
oxidase assembly on the phagosome membrane [17,S71].
Leishmania also prevent NADPH oxidase assembly through surface
LPG, which serves a dual role by also scavenging ROIs directly
[S72,S35].
Apart from targeting NADPH assembly and activation, many
pathogens express enzymes that neutralize ROIs. L. monocytogenes
[S73], Salmonella [18], Yersinia [S74], F. tularensis [S75], and Mtb
[S76,S77] all express surface-associated and cytoplasmic superox-
ide dismutases, which scavenge superoxide radicals. In addition,
many of these pathogens also secrete catalase-peroxidase, which
breaks down H2O2 [S78–S82].
The catalase-peroxidases of Salmonella and Mtb can also act as
peroxynitritases that deactivate peroxynitrite formed when nitric
oxide (produced by inducible nitric oxide synthase [iNOS]) reacts
with superoxide [19,S80]. T. cruzi also deactivates peroxynitrite,
which is critical for pathogen survival within the host macrophage
[S83]. The expression of iNOS and production of reactive
nitrogen intermediates (RNIs) is a critical macrophage microbici-
dal mechanism dependent upon the oxidation of L-arginine. iNOS
activity competes for this amino acid with arginase 1, which
promotes the production of urea. Mtb skews the balance by
upregulating arginase expression via autocrine cytokine signaling
in infected macrophages in order to curtail iNOS activity [20]. If
RNIs are indeed formed, certain microorganisms have detoxifi-
cation mechanisms to call upon, such as Salmonella factors secreted
by Type III secretion [21], and the truncated hemoglobins of Mtb
[S84], Mycobacterium bovis [S85], and Mycobacterium leprae [S86]. In
parallel with detoxification of RNIs, Salmonella also repair
nitrosative damage using flavohemoglobins [22], flavorubredoxin,
and cytochrome C nitrite reductase [S87].
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Supports an Intracellular Lifestyle
When macrophages fail to eliminate infecting pathogens,
programmed cell death is often initiated as a last resort to resolve
the infection. Three major modes of cell death may occur in
response to infection: apoptosis, necrosis, and pyroptosis. Apop-
tosis is characterised by retention of membrane integrity coupled
with the formation of apoptotic bodies and is generally viewed as
being immunologically silent. Apoptotic cells are engulfed by
neighbouring phagocytes, which may result in pathogen degrada-
tion and initiation of adaptive immunity. In contrast, necrosis and
pyroptosis trigger rapid inflammatory responses, as necrotic and
pyroptotic cells secrete pro-inflammatory cytokines and release
cytoplasmic contents extracellularly.
In order to retain their intracellular niche, many intracellular
pathogens prevent host cell death. A major mechanism to inhibit
apoptosis is interference with caspase signaling cascades. Inhibi-
tion of effector caspases 3 and 8 has been observed during
infection with T. gondii [S88] and T. cruzi [S89]. Activation of
caspase death cascades can also be subverted by preventing
cytochrome C release from mitochondria, a strategy shared by T.
gondii [S90] and Leishmania [S91]. Other pro-survival, host
signaling cascades exploited by pathogens to confer resistance to
apoptosis are activation of the PI3K/Akt axis by L. major and L.
amazonensis [5] and T. gondii [23] and activation of NFkBb y
Ehrlichia chaffeensis [S92], L. monocytogenes [S93], and L. pneumophila
[S94,S95]. Activation of these pathways results in the upregulation
of pro-survival molecules of the Bcl-2 family, inhibition of
cytochrome C release, and activation of inhibitor of apoptosis
proteins (IAPs). Additional strategies to inhibit apoptosis include
expression of orthologs of host anti-apoptotic molecules, such as
macrophage migration inhibitory factor by L. major [S96], or
induction of anti-apoptotic heat shock proteins by T. gondii [S97].
Prevention of pyroptotic cell death has been demonstrated for
Yersinia enterocolitica and Mtb, brought about by inhibition of
caspase-1 activation and inflammasome formation [24,S98].
Conversely, several pathogens induce cell death in order to
promote dissemination, or to evade systemic immunity or both.
Whereas intracellular pathogens generally avoid initiating pro-
inflammatory necrosis or pyroptosis, initiation of macrophage
apoptosis may benefit the pathogen by promoting dissemination to
other macrophages without activating them and often reflects a
productive infectious cycle. Initiation of macrophage apoptosis has
been reported for T. cruzi [25], L. major, Leishmania aethiopica, and
Leishmania tropica [26], and Yersinia pseudotuberculosis [27,S99]. The
fact that both T. cruzi and Leishmania spp. have been shown to be
capable of either preventing or inducing apoptosis at first blush
appears paradoxical. It seems plausible, however, that these
juxtaposed behaviours may reflect different stages of infection.
Thus, prevention of apoptosis early after infection may allow for
preservation of the intracellular niche and replication, whereas
during late stage infection, induction of apoptosis facilitates
pathogen release, dissemination, and silent uptake by other
macrophages. This behaviour is also exhibited by virulent Mtb,
which has been shown to prevent apoptosis, but induce necrosis of
infected macrophages to promote the spread of bacilli [28,S100].
It has further been shown that T. gondii [S101], Leishmania donovani
[S102], and M. bovis [S103] induce apoptosis of non-infected
bystander cells to deplete monocytes, macrophages, and CD4
+
and/or CD8
+ T cells.
Concluding Remarks
Intracellular pathogens have evolved a wide and diverse range
of strategies to avoid or defend against macrophage innate
immune effector mechanisms. In response, macrophages are
equipped with various countermeasures such as phosphorylating
secreted microbial superoxide dismutases to inactivate them [29]
and the production of host proteins that recognize and bind to
microbial iron chelators, thereby preventing pathogen iron uptake
[30,S104]. A deeper understanding of these macrophage coun-
termeasures and their regulation, as well as how pathogens
regulate their own responses to the macrophage environment, will
prove to be fertile ground for developing targeted therapeutic
strategies in years to come.
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